News Stories Related To: Drug combo helps slow lung cancer
By: petergill 
The combination of two anti-cancer treatments following standard chemotherapy can slow advanced non-small cell lung cancer, according to a study unveiled Saturday. Patients...
-
- Share:
-
-
-
-
-
- Read full report
Reach
Credibility 
READ MORE: Drug combo helps slow lung cancer
Reported by Peter Gill
Cell phones use report code: Related news stories
- Add A News Story |
- Filter By:
- All
- | Local
- News Source: Androscoggin News | 5 months agoThe numbers would look better if drug companies did a better job of targeting drugs at the patients most likely to benefit. But that targeting has occurred in only a few scattered examples. The skyrocketing costs for limited benefit are leading some...
- News Source: Androscoggin News | 5 months agoas first-line maintenance treatment benefited from a significant (29%) improvement in the time they lived without the disease advancing, compared with those who received placebo1. UK, received maintenance treatment with erlotinib if their cancer had...
- News Source: Chicago Tribune | 5 months agoTwo years after it was formed, a Chicago nonprofit group is making strides understanding why some people are predisposed to dangerous drug interactions and serious illness when taking prescriptions. The International Serious Adverse Event Consortium...
- News Source: Sify News | 5 months agoDrug developers AstraZeneca PLC and Merck&Co. said Monday they will jointly develop a combination treatment for cancer. The companies said they will combine efforts with Merck's MK-2206 and AstraZeneca's AZD6244, both of which are still in very early...
- News Source: NewKerala | 5 months agoWhile studying the relationship between death rates from lung cancer and how much a person smoked, researchers at West Virginia University found that smoking intensity predicts how the disease will progress. They found that patients who smoked two...
- News Source: Press TV | 5 months agoPrevious studies had reported bevacizumab (Avastin) and erlotinib (Tarceva) as effective medications in blocking the tumor growth in non-small cell lung cancer. A new study, however, showed adding erlotinib to maintenance therapy with bevacizumab in...
- News Source: Androscoggin News | 5 months agopatients who have become intolerant or resistant to standard therapies. June 2, in Orlando, FL. "Subcutaneous Omacetaxine Mepesuccinate in Chronic Myeloid Leukemia (CML) Patients Resistant or Intolerant to Two or More Tyrosine Kinase Inhibitors (TKIs)...
Site Links
Site Topics
Contributions
- Report Your News
- Add your voice and contribute via your cellphone - check out how to Report News via Your Cellphone
- Blog Widget
- Widget for Blog Owner
